Image-derived Prediction of Response to Chemo-radiation in Glioblastoma
NCT02329795
·
clinicaltrials.gov ↗
TERMINATED
Status
16
Enrollment
OTHER
Sponsor class
Stopped
Slow accrual
Conditions
Glioblastoma
Interventions
RADIATION:
Radiotherapy
DRUG:
Temozolomide
Sponsor
Rigshospitalet, Denmark